Autopsy report · NCT05379179
Ketamine Pilot Study
Cause of deathSlow enrollment
“After 20 months of active enrollment and a lack of qualified/interested subjects, the Investigator, Meghan Spyres, MD, decided to terminate recruitment before meeting the stated enrollment objectives.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 1 year 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Meghan Spyres
- Sponsor type
- University, hospital or other
- Conditions
- Rattlesnake Envenomation
- Interventions
- Ketamine; Fentanyl
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition
“The study was terminated prematurely because of difficulty with recruiting.” - A Study to Determine the Performance of the Press Fit Condylar (P.F.C.) Sigma RP-F Knee System
“Study was terminated early due to prolonged recruitment period.” - Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab
“Study was terminated early because of slow recruitment” - Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis
“Study terminated early due to difficulties in subject recruitment” - THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS)
“Study terminated due to slow recruitment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.